Table 1 Characteristics of IFX-treated patients and untreated healthy controls
From: B cell epitopes on infliximab identified by oligopeptide microarray with unprocessed patient sera
Patients | Untreated controls | |
|---|---|---|
Mean age | 37 y | 35 y |
Gender distribution | 60 % female | 75 % female |
Mean ADA level | 51 µg/ml | <1.25 µg/ml |